In a report released yesterday, Barry Oxford from Colliers Securities maintained a Buy rating on American Healthcare REIT, Inc. (AHR – Research Report), with a price target of $33.00.
Barry Oxford has given his Buy rating due to a combination of factors including American Healthcare REIT’s strong financial performance and strategic acquisitions. The company reported impressive same-store NOI growth of 21.6% in the recent quarter, driven by significant gains in their “SHOP” properties and integrated senior health campuses. This robust performance is complemented by the company’s strategic acquisition of a minority stake in Trilogy, enhancing its portfolio and growth potential.
Additionally, the company’s balance sheet is strong, with a significant reduction in Net-Debt-to-Annualized Adjusted EBITDA from the previous year, indicating improved financial health. Despite expectations of slower growth in 2025, the company has provided guidance suggesting continued solid internal growth. These factors, combined with a strategic focus on expanding their portfolio through acquisitions and maintaining a healthy balance sheet, underpin Barry Oxford’s Buy rating for American Healthcare REIT.
According to TipRanks, Oxford is a 4-star analyst with an average return of 3.5% and a 63.18% success rate. Oxford covers the Real Estate sector, focusing on stocks such as Postal Realty, Mid-America Apartment, and AvalonBay.